Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer

Peritoneal Carcinomatosis: Drugs and Diseases - Cancer Treatment and Research ◽

10.1007/978-1-4613-1245-1_14 ◽

1996 ◽

pp. 169-176 ◽

Author(s):

Shigeru Fujimoto ◽

Makoto Takahashi ◽

Takaaki Mutou ◽

Kokuriki Kobayashi ◽

Tadashi Toyosawa ◽

...

Keyword(s):

Gastric Cancer ◽

Side Effects ◽

Survival Time ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Intraperitoneal Hyperthermic Perfusion

Download Full-text

O-13 Gut microbiome to predict survival time in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08)

Annals of Oncology ◽

10.1016/j.annonc.2021.05.017 ◽

2021 ◽

Vol 32 ◽

pp. S223-S224

Author(s):

Y. Sunakawa ◽

R. Matoba ◽

E. Inoue ◽

Y. Sakamoto ◽

R. Kawabata ◽

...

Keyword(s):

Gastric Cancer ◽

Survival Time ◽

Advanced Gastric Cancer ◽

Download Full-text

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

Gastric Cancer ◽

10.1007/s10120-011-0030-8 ◽

2011 ◽

Vol 14 (3) ◽

pp. 226-233 ◽

Author(s):

Tetsuya Hamaguchi ◽

◽

Kuniaki Shirao ◽

Atsushi Ohtsu ◽

Ichinosuke Hyodo ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group

Download Full-text

1240 RAD001 plus mitomycin C, every three weeks in previously treated patients with advanced gastric cancer or cancer of the esophagogastric junction – preliminary results of a Phase I study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70452-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 132

Author(s):

S.E. Al-Batran ◽

C. Pauligk ◽

S. Janowski ◽

K. Steinmetz ◽

A. Atmaca ◽

...

Keyword(s):

Gastric Cancer ◽

Phase I ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Phase I Study ◽

Esophagogastric Junction ◽

Preliminary Results ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

NRP‑1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer

Oncology Letters ◽

10.3892/ol.2019.10842 ◽

2019 ◽

Author(s):

Yue‑Jian Zhuo ◽

Yu Shi ◽

Tao Wu

Keyword(s):

Gastric Cancer ◽

Survival Time ◽

Advanced Gastric Cancer

Download Full-text

Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis

Cancer ◽

10.1002/1097-0142(19921215)70:12<2754::aid-cncr2820701205>3.0.co;2-a ◽

1992 ◽

Vol 70 (12) ◽

pp. 2754-2760 ◽

Author(s):

Shigeru Fujimoto ◽

Makoto Takahashi ◽

Kokuriki Kobayashi ◽

Kohji Nagano ◽

Masanobu Kure ◽

...

Keyword(s):

Gastric Cancer ◽

Mitomycin C ◽

Peritoneal Metastasis ◽

Antitumor Effects ◽

Intraperitoneal Hyperthermic Perfusion

Download Full-text

5-Fluorouracil Versus a Combination of BCNU, Adriamycin, 5- FU and Mitomycin C in Advanced Gastric Cancer: A Prospective Randomized Study of the Italian Clinical Research Oncology Group

Combined Modality Therapy of Gastrointestinal Tract Cancer - Recent Results in Cancer Research ◽

10.1007/978-3-642-83293-2_33 ◽

1988 ◽

pp. 212-218 ◽

Author(s):

V. De Lisi ◽

G. Cocconi ◽

M. Tonato ◽

F. Di Costanzo ◽

F. Leonardi ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Research ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Randomized Study ◽

Prospective Randomized Study ◽

Download Full-text

Open Phase II with 5-Fluorouracil, 4-Epi-Doxorubicin and Mitomycin C (Fem) in Advanced Gastric Cancer

Tumori Journal ◽

10.1177/030089169007600113 ◽

1990 ◽

Vol 76 (1) ◽

pp. 51-53 ◽

Author(s):

Anton Roth ◽

Darko Županc ◽

Josip Luetić ◽

Krsto Kolarić

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Download Full-text

What Is the Role of Mitomycin C in Advanced Gastric Cancer?

Oncology Research and Treatment ◽

10.1159/000083421 ◽

2005 ◽

Vol 28 (3) ◽

pp. 125-126 ◽

Author(s):

Geoff Chong ◽

David Cunningham

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Download Full-text

A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer

Japanese Journal of Cancer Research ◽

10.1111/j.1349-7006.1991.tb01894.x ◽

1991 ◽

Vol 82 (5) ◽

pp. 613-620 ◽

Author(s):

Minoru Kurihara ◽

Tuguhiko Izumi ◽

Shigeaki Yoshida ◽

Toshiharu Ohkubo ◽

Shoji Suga ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Randomized Study

Download Full-text

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

Anti-Cancer Drugs ◽

10.1097/00001813-199909000-00006 ◽

1999 ◽

Vol 10 (8) ◽

pp. 729-734 ◽

Author(s):

J T Hartmann ◽

D Quietzsch ◽

T Daikeler ◽

C Kollmannsberger ◽

F Mayer ◽

...

Keyword(s):

Gastric Cancer ◽

Continuous Infusion ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Salvage Chemotherapy ◽

Pretreated Patients

Download Full-text